Home JNJ
163.36
  Price0.76%   -1.25
(Pre-market: 163.32 -0.04 -0.02% )
loading

Johnson & Johnson (JNJ) Latest News

Feb-06-23 11:01AM AbbVie (ABBV) to Report Q4 Earnings: What's in the Cards?Zacks Investment Research
10:30AM Biotech Stocks' Q4 Earnings Due on Feb 7: VRTX, INCY and EXELZacks Investment Research
Feb-06-23 09:40AM Why Johnson & Johnson (JNJ) is a Top Value Stock for the Long-TermZacks Investment Research
09:05AM Johnson & Johnson's Latest Talcum Powder Development Could Be CostlyThe Motley Fool
Feb-06-23 02:12AM Biogen: What To Do Ahead Of Q4 2022 Financial ReportSeeking Alpha
Feb-03-23 09:19AM Pharma Stock Roundup: MRK, LLY, PFE Q4 Results, J&J's Loss in Talc LawsuitsZacks Investment Research
05:06AM 3 Dow Stocks That Make for Screaming Buys in FebruaryThe Motley Fool
Feb-02-23 01:21AM Johnson & Johnson's Upcoming Lung Cancer Data Could Offer Another Blockbuster Opportunity, Says AnalystBenzinga
10:59AM 3 Dividend Aristocrats to Buy NowInvesting.com
Feb-02-23 08:59AM Looking for a Reliable Dividend Payer? Consider Buying This Blue-Chip StockThe Motley Fool
07:45AM 3 Dividend Stocks to Buy in 2023 for a Lifetime of Passive IncomeThe Motley Fool
Feb-02-23 06:20AM Is Johnson & Johnson Stock Worth Buying on the Dip?The Motley Fool
06:10AM This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 YearsThe Motley Fool
Feb-01-23 10:39AM GSK's Beats on Q4 Earnings & Sales, Issues Upbeat 2023 OutlookZacks Investment Research
06:05AM 3 Stocks You Can Confidently Buy in a Market DownturnThe Motley Fool
Feb-01-23 05:06AM 3 Warren Buffett Stocks to Buy Hand Over Fist in FebruaryThe Motley Fool
Jan-31-23 08:26AM Earnings Roundup: Tesla, Intel, Chevron, and MoreThe Motley Fool
11:00AM Sony Scales Back PlayStation VR2 Output, Sam Bankman-Fried Attempted To Regain Control Of FTX, White House Plans To End COVID-19 Emergency: Today's Top StoriesBenzinga
Jan-31-23 10:52AM J&J (JNJ) Down as Court Rejects Bankruptcy Claim in Talc LawsuitsZacks Investment Research
09:34AM Company News for Jan 31, 2023Zacks Investment Research
Jan-31-23 07:05AM Wall Street Breakfast Podcast: IMF: U.S. Could Avoid Recession In 2023Seeking Alpha
05:05AM Is Visa Stock a Buy?The Motley Fool
Jan-30-23 03:21AM S&P 500 sinks to session low in afternoon trade as Fed decision, tech earnings loomMarketWatch
02:24AM Dow sheds about 200 points, Nasdaq leads stock market lower as Fed decision, tech earnings loomMarketWatch
Jan-30-23 12:16PM Nasdaq falls 1.2% to lead stock market lower as Fed decision, tech earnings awaitMarketWatch
09:00AM Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research
Jan-30-23 08:08AM 3 Dividend Kings to Buy Hand Over Fist in 2023The Motley Fool
Jan-27-23 12:05PM The Best S&P 500 Index FundsThe Motley Fool
08:14AM Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study EndsZacks Investment Research
Jan-27-23 06:20AM Should iShares Russell 1000 Value ETF (IWD) Be on Your Investing Radar?Zacks Investment Research
Jan-26-23 10:00AM ETFs in Focus on JNJ's Mixed Q4 Earnings ResultsZacks Investment Research
09:45AM 3 Warren Buffett Stocks That Could Make You Richer in 2023The Motley Fool
Jan-26-23 06:20AM Should Schwab U.S. LargeCap Value ETF (SCHV) Be on Your Investing Radar?Zacks Investment Research
05:33AM Is Johnson & Johnson Still a Good Dividend Stock to Buy?The Motley Fool
Jan-26-23 05:06AM 3 Perfect Stocks for Retirees to Buy Hand Over Fist During the Nasdaq Bear MarketThe Motley Fool
Jan-25-23 02:39AM China’s Lunar New Year celebrations raise concerns about COVID spread, while officials say peak is pastMarketWatch
11:45AM Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?Zacks Investment Research
Jan-25-23 10:17AM China’s Lunar New Year celebrations raise concerns about COVID spread, while officials say peak is pastMarketWatch
09:30AM Stock Market News for Jan 25, 2023Zacks Investment Research
Jan-25-23 07:37AM Union Pacific To Rally Over 11%? Here Are 10 Other Analyst Forecasts For WednesdayBenzinga
06:20AM Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Hopes — Analyst Warns Of More Bumpiness By Mid-FebruaryBenzinga
Jan-25-23 06:20AM Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?Zacks Investment Research
05:50AM 3 Reasons Why Johnson & Johnson Stock Could Rebound After a Bad Start in 2023The Motley Fool
Jan-24-23 04:58AM J&J: 'Tripledemic' fueled demand for Motrin and TylenolMarketWatch
04:41AM Dow books third straight day of gains, but Nasdaq and S&P 500 end lower as investors await big tech earningsMarketWatch
Jan-24-23 04:30AM Johnson & Johnson (JNJ) Q4 2022 Earnings Call TranscriptThe Motley Fool
03:44AM Dow edges up but stocks waver in final hour of trade as investors weigh earnings reports, await big tech resultsMarketWatch
Jan-24-23 01:50AM FDA backs annual COVID vaccine for Americans with strain to be decided midyearMarketWatch
01:05AM 'Tripledemic' demand for Motrin and Tylenol fueled year-end sales in J&J’s consumer businessMarketWatch
Jan-24-23 12:33PM Johnson & Johnson (JNJ) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Cap:    |  Volume (24h):